Dysautonomia Clinical Trial
Official title:
Study Title: Brain Transmitters/Metabolites, Magnetic Resonance Spectroscopy, and Brain Connectivity: Diagnostic Strategies to Study the Effects of Non-Pharmacologic Therapies for Dysautonomia and Chronic Nausea
Verified date | April 2018 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this research study is to better understand what causes dysautonomia and how this affects blood pressure and pulse. Dysautonomia is a condition of the autonomic nervous system. It is associated with fluctuations in blood pressure and pulse and may cause symptoms of nausea and belly pain, fatigue, excessive thirst, lightheadedness, dizziness, feelings of anxiety or panic, and fainting. A common example of dysautonomia is postural orthostatic tachycardia syndrome or POTS. Sometimes symptoms worsen when people move from lying down to standing, called orthostatic intolerance. We would like to learn more about the link between orthostatic intolerance and nausea. While medications currently used to treat orthostatic intolerance and nausea have proven to be effective in some patients, this may not be the best treatment for everyone as long term use could pose certain risks including high blood pressure. In order to provide a more focused and safer treatment for patients suffering from nausea and orthostatic intolerance, we have looked at how the blood pressure, pulse, and certain blood tests change during a tilt table test. This test helps to create the same circumstances that patients with orthostatic intolerance experience when they stand. To better understand if some of these problems are associated with the brain, we will study MRI in patients with dysautonomia compared to children without dysautonomia. This information may allow us to use alternative and safer treatments in the future.
Status | Completed |
Enrollment | 22 |
Est. completion date | June 11, 2013 |
Est. primary completion date | June 11, 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 9 Years to 18 Years |
Eligibility |
Inclusion Criteria: - subjects who have completed tilt autonomic testing - subjects from 9 - 18 years of age Exclusion Criteria: - subjects who have a metabolic, mechanical, or mucosal inflammatory cause which has been defined to explain their gastrointestinal symptoms - Patients with cardiac or cardiovascular disease, malignancy, psychiatric illness, neurodevelopmental delay, or other co-morbid conditions - Patients with with pacemakers, implanted devices, or any other MRI contraindications will be excluded from this study. |
Country | Name | City | State |
---|---|---|---|
United States | Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University Health Sciences |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the implication of dysautonomia on the brain and better evaluate its potential mechanistic process. | The first objective of the proposed project is to study central transmitter/metabolite profiles using in vivo 1H Magnetic Resonance Spectroscopy (MRS) in children with dysautonomia diagnosed by tilt table testing compared to healthy children without symptoms of dysautonomia. The second objective will be to determine whether dysautonomia associated with nausea and cardiovascular instability shares common alterations in brain networks. We will be using cognitive and sensory processing tasks based on our prior experience with both traditional fMRI and network analyses. | Assessments will occur in a one and a half hour visit. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Completed |
NCT00565526 -
Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
|
||
Recruiting |
NCT05741112 -
The Long COVID-19 Wearable Device Study
|
N/A | |
Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
Completed |
NCT03185247 -
Implementation of Transdx Group for POTS
|
N/A | |
Completed |
NCT01367977 -
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
|
||
Terminated |
NCT00221689 -
Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients
|
Phase 2 | |
Recruiting |
NCT05041387 -
Data Collection of Standard Care of Patients in the EMG Section
|
||
Recruiting |
NCT05681455 -
Physiotherapy for Persistent Function by Superficial Neuromodulation
|
N/A | |
Withdrawn |
NCT01343329 -
Controlling Hyperadrenergic Activity in Neurologic Injury
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05638620 -
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
|
Phase 1 | |
Not yet recruiting |
NCT06073886 -
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
|
Phase 2 | |
Completed |
NCT03674541 -
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT05566379 -
Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia
|
N/A | |
Recruiting |
NCT05855356 -
Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial
|
N/A | |
Completed |
NCT04121338 -
Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility
|
Phase 1 | |
Recruiting |
NCT05400174 -
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
|
N/A | |
Recruiting |
NCT02931773 -
Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2)
|
N/A | |
Not yet recruiting |
NCT04502199 -
Dysautonomic Phenotype in Male Patients With MECP2 Mutation
|
||
Active, not recruiting |
NCT05515640 -
Dysautonomia and Systemic Interactions in Traumatic Brain Injury
|